-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target

Benzinga·03/26/2025 11:23:30
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.